Akt is a key player in the growth of colon tumors; it stops GSK3β/APC/axin from breaking down β-catenin and increases the expression of oncogenes like c-Myc and cyclin D1 that target β-catenin (Shojaei-Zarghani et al., 2020). Here, GSK3B is linked to colonic neoplasm.